Ofev, which is under review for the treatment of people with chronic fibrosing interstitial lung diseases (ILDs), has been given Breakthrough Therapy Designation.
List view / Grid view
Regs & Legs
Filter the results
The Secretary of State for Health and Social Care is supporting the continuity of medical supplies if the UK is to leave the EU without a deal.
A jury has said that Johnson & Johnson must pay $8 billion in the case over male breast growth linked to Risperdal.
California’s state governor has signed a bill which will stop drug makers from paying generic drug producers to stay off the market.
The FDA has approved the first treatment to increase pain-free light exposure in patients with the rare disorder, erythropoietic protoporphyria.
The CQC decision marks the first time the agency has accepted a clinic to prescribe patients with medical cannabis in the UK.
Researchers have found three factors that must be taken into account when compiling an essential medicines list for Canada.
The FDA has given the designation to niraparib for the treatment of gene-mutated castration-resistant prostate cancer.
The UK Competition and Markets Authority has alleged that Aspen paid two other pharmaceutical companies to ensure they were the only supplier of a drug to the NHS.
The FDA has announced its approval of Descovy, a PrEP method therapy, to reduce the risk of HIV-1 infection from sex.
4 October 2019 | By Mettler-Toledo GmbH
This webinar provides an overview of the important UV/Vis spectroscopy-relevant changes in both USP and Ph. Eur. taking a closer look at their impact and the solutions available to ensure compliance.
The FDA recommends drug manufacturers to use LC-HRMS to test for NDMA in ranitidine products, as high temperatures generate the impurity.
The government has announced new measures to prevent parallel exporting to ease the supply chain, in an effort to reduce medicine shortages.
The FDA and DEA have, for the first time, sent joint warning letters to four networks which were illegally selling opioid products.